Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Merck & Co., Inc : Good timing to go long again

03/26/2020 | 09:15am EST
long trade
Target price hit
Entry price : 70.17$ | Target : 77.7$ | Stop-loss : 65.9$ | Potential : 10.73%
The medium term support area around 66.4 USD should allow Merck & Co., Inc shares to re-establish an upward trend in the short term.
Investors have an opportunity to buy the stock and target the $ 77.7.
Merck & Co., Inc : Merck & Co., Inc : Good timing to go long again
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

Strengths
  • The share is getting closer to its long-term support in weekly data, at USD 66.58, which offers good timing for buyers.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the USD 66.4 support.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses
  • The company's earnings releases usually do not meet expectations.
  • The company's enterprise value to sales, at 3.79 times its current sales, is high.
  • The underlying tendency is negative on the weekly chart below the resistance at 79.73 USD

© MarketScreener.com 2020
Stocks mentioned in the article
ChangeLast1st jan.
BYD COMPANY LIMITED 4.27% 244 End-of-day quote.20.08%
MERCK & CO., INC. -0.88% 82.46 Delayed Quote.1.70%

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2020 48 200 M - -
Net income 2020 12 145 M - -
Net Debt 2020 15 159 M - -
P/E ratio 2020 17,6x
Yield 2020 2,94%
Capitalization 210 B 210 B -
EV / Sales 2020 4,68x
EV / Sales 2021 4,31x
Nbr of Employees 71 000
Free-Float 70,7%
Upcoming event on MERCK & CO., INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Average target price 96,95 $
Last Close Price 83,19 $
Spread / Highest target 28,6%
Spread / Average Target 16,5%
Spread / Lowest Target 2,18%
EPS Revisions
Managers and Directors
NameTitle
Kenneth C. Frazier Chairman, President & Chief Executive Officer
Robert M. Davis CFO & Executive Vice President-Global Services
Sandy Tremps Vice President-R&D IT CIO
Thomas Henry Glocer Independent Director
Leslie A. Brun Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MERCK & CO., INC.1.70%210 474
JOHNSON & JOHNSON3.43%428 525
ROCHE HOLDING AG2.98%307 190
NOVARTIS AG2.24%218 823
PFIZER INC.-0.22%204 160
ABBVIE INC.4.69%198 051